Tha Tun, Martini Iana, Stefan Elena, Redla Sridhar
Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.
The Princess Alexandra Hospital NHS Trust, Harlow, UK.
BJR Case Rep. 2022 Jan 10;8(2):20210139. doi: 10.1259/bjrcr.20210139. eCollection 2022 Mar 10.
Vaccine-induced thrombotic thrombocytopaenia (VITT) is a rare syndrome associated with the ChAdOx1 nCoV-19 (AstraZeneca) vaccine. We detail a case of vaccine-induced thrombotic thrombocytopaenia in a 47-year-old female who was found to have bilateral adrenal haemorrhage, renal vein thrombosis, renal infarction and pulmonary embolism 13 days post-vaccination with ChAdOx1 nCoV-19.
疫苗诱导的血栓性血小板减少症(VITT)是一种与ChAdOx1 nCoV-19(阿斯利康)疫苗相关的罕见综合征。我们详细介绍了一例47岁女性的疫苗诱导的血栓性血小板减少症病例,该患者在接种ChAdOx1 nCoV-19疫苗13天后出现双侧肾上腺出血、肾静脉血栓形成、肾梗死和肺栓塞。